VG Life Sciences Inc.
Income Statement
| Line Item | FY2014 | FY2013 |
|---|---|---|
| Revenue | $0 | $0 |
| Cost of Revenue | — | — |
| Gross Profit | — | — |
| Gross Margin | — | — |
| Operating Expenses | ||
| Research & Development | $865.7K | $808.5K |
| SG&A Expense | $911.4K | $1.4M |
| Operating Income | $-4.1M | $-3.9M |
| Operating Margin | — | — |
| Interest Expense | $2.8M | $1.1M |
| Pretax Income | — | — |
| Income Tax Expense | $0 | $0 |
| Net Income | $-6.2M | $-7.4M |
| Net Margin | — | — |
| EPS (Basic) | $-0.22 | $-0.91 |
| EPS (Diluted) | $-0.22 | $-0.91 |
| Shares Outstanding (Basic) | 46.2M | 17.5M |
| Shares Outstanding (Diluted) | 46.2M | 17.5M |
| Dividends Per Share | — | — |